Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Home Transcutaneous Electrical Acustimulation (TEA)

NCT: NCT05519683 · RECRUITING

NCT IDNCT05519683
StatusRECRUITING
Start Date2022-11-02
Completion2027-03
SponsorUniversity of Michigan (OTHER)
First posted
Last updated

Brief Summary

This study will assess the efficacy of two active treatments with TEA and a chemical neuromodulator (escitalopram aka Lexapro) versus a sham comparator or control group on abdominal pain.

Frequently Asked Questions

What is Home Transcutaneous Electrical Acustimulation (TEA)?

Home Transcutaneous Electrical Acustimulation (TEA) is a clinical trial registered under NCT05519683. Current status: RECRUITING.

What is the status of NCT05519683?

The current status of NCT05519683 (Home Transcutaneous Electrical Acustimulation (TEA)) is: RECRUITING.

When did Home Transcutaneous Electrical Acustimulation (TEA) start?

Home Transcutaneous Electrical Acustimulation (TEA) started on 2022-11-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑